Harvard Bioscience (HBIO) Income from Continuing Operations (2010 - 2026)
Harvard Bioscience (HBIO) reported Income from Continuing Operations of 3424000.0 for Q1 2026, up 93.19% year-over-year from 1772329.83 in Q1 2025, and down 0.71% on a QoQ basis from 3400000.0 in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Income from Continuing Operations data on file, last reported at 3424000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 93.19% year-over-year to 3424000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10337000.0 (up 82.16% YoY) and the FY2025 annual result came in at 57253000.0, down 361.53% from the prior year.
- Income from Continuing Operations fell to 3424000.0 in Q1 2026 per HBIO's latest filing, from 3400000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2421000.0 in Q2 2022 and bottomed at 50294000.0 in Q1 2025.
- The 5-year median for Income from Continuing Operations is 2282000.0 (2025), against an average of 5072176.47.
- The widest annual swing landed in 2022, when Income from Continuing Operations surged 660.42%; it then plunged 18988.89% in 2025.
- Tracing HBIO's Income from Continuing Operations over 5 years: stood at 2164000.0 in 2022, then increased by 26.52% to 1590000.0 in 2023, then jumped by 101.13% to 18000.0 in 2024, then sank by 18988.89% to 3400000.0 in 2025, then declined by 0.71% to 3424000.0 in 2026.
- Per Business Quant, the three latest HBIO Income from Continuing Operations figures stand at 3424000.0 (Q1 2026), 3400000.0 (Q4 2025), and 1231000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -17.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.42 Mn |
| Dec 31, 2025 | -3.40 Mn |
| Sep 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -50.29 Mn |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | -4.80 Mn |
| Jun 30, 2024 | -2.88 Mn |
| Mar 31, 2024 | -4.69 Mn |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | -1.24 Mn |
| Jun 30, 2023 | -980,000.00 |
| Mar 31, 2023 | 622,000.00 |
| Dec 31, 2022 | -2.16 Mn |
| Sep 30, 2022 | -3.39 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | -6.92 Mn |
| Dec 31, 2021 | 590,000.00 |
| Sep 30, 2021 | -170,000.00 |
| Jun 30, 2021 | -432,000.00 |
| Mar 31, 2021 | -669,000.00 |
| Dec 31, 2020 | -709,000.00 |
| Sep 30, 2020 | -1.12 Mn |
| Jun 30, 2020 | -1.58 Mn |
| Mar 31, 2020 | -4.52 Mn |
| Dec 31, 2019 | 550,000.00 |
| Sep 30, 2019 | -2.57 Mn |
| Jun 30, 2019 | -232,000.00 |
| Mar 31, 2019 | -2.37 Mn |
| Dec 31, 2018 | 3.31 Mn |
| Sep 30, 2018 | -256,000.00 |
| Jun 30, 2018 | -1.50 Mn |
| Mar 31, 2018 | -5.85 Mn |
| Dec 31, 2017 | -11,000.00 |
| Sep 30, 2017 | -645,000.00 |
| Jun 30, 2017 | -617,000.00 |
| Mar 31, 2017 | -743,000.00 |
| Dec 31, 2016 | -1.32 Mn |
| Sep 30, 2016 | -1.64 Mn |
| Jun 30, 2016 | -713,000.00 |
| Mar 31, 2016 | -636,000.00 |
| Dec 31, 2015 | -17.14 Mn |
| Sep 30, 2015 | -847,000.00 |
| Jun 30, 2015 | 349,000.00 |
| Mar 31, 2015 | -1.40 Mn |
| Dec 31, 2014 | -19,000.00 |
| Sep 30, 2014 | 633,000.00 |
| Jun 30, 2014 | 1.02 Mn |
| Mar 31, 2014 | 719,000.00 |
| Dec 31, 2013 | -255,000.00 |
| Sep 30, 2013 | -49,000.00 |
| Jun 30, 2013 | 95,000.00 |
| Mar 31, 2013 | 932,000.00 |
| Dec 31, 2012 | 1.17 Mn |
| Sep 30, 2012 | 700,000.00 |
| Jun 30, 2012 | 1.55 Mn |
| Mar 31, 2012 | 1.07 Mn |
| Dec 31, 2011 | 738,000.00 |
| Sep 30, 2011 | 28,000.00 |
| Jun 30, 2011 | 1.37 Mn |
| Mar 31, 2011 | 1.68 Mn |
| Dec 31, 2010 | -4.66 Mn |
| Sep 30, 2010 | 12.73 Mn |
| Jun 30, 2010 | 1.88 Mn |